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Bilateral intradentate injections of 3.0 lg of colchicine induced a substantial loss of granule cells and
damage to the overlying pyramidal cell layer in region CA1 in adult male Long-Evans rats. All rats with
such lesions showed a signiﬁcant associative learning deﬁcit in an olfactory discrimination task, while
being unimpaired in the procedural component of this task. Injection of a partial selective 5-HT4 agonist
(SL65.0155; 0.01 mg/kg, i.p., vs. saline) before the third of six training sessions enabled complete recovery
of associative learning performance in the lesioned rats. Activation of 5-HT4 receptors by a selective ago-
nist such as SL65.0155 might therefore provide an opportunity to reduce learning and memory deﬁcits
associated with temporal lobe damage, and could be useful for the symptomatic treatment of memory
dysfunctions related to pathological aging such as Alzheimer’s disease.
 2008 Elsevier Inc. All rights reserved.1. Introduction
Although the etiology of Alzheimer’s disease (AD) is still under
discussion, neuroﬁbrillary tangles and amyloïd plaques have been
recognized as the pathological hallmarks of this disease since the
early report by Alzheimer (1907). These hallmarks are associated
with evidence of neurodegeneration in a variety of brain regions
involved in cognitive functions, including the basal forebrain, the
hippocampus and some retrohippocampal regions such as the
entorhinal cortex. Since the pioneering work by Perry et al.
(1978), AD-related cognitive dysfunctions have been attributed
to cholinergic degeneration in the basal forebrain, but other neuro-
transmitter systems are also altered, including the norepinephri-
nergic, dopaminergic, and serotonergic systems (see Palmer,
2002 for a review), and all contribute to cognitive functions. These
non-cholinergic systems provide other potential targets for symp-
tomatic intervention, either alone or in combination with pro-cho-
linergic compounds.
Concerning the serotonergic system, the substantial expression
of 5-HT4 receptors in limbic areas suggests that this receptor type
could contribute to learning and memory functions, perhaps indi-
rectly by modulating acetylcholine release in these structures
(Consolo, Arnaboldi, Giorgi, Russi, & Ladinsky, 1994). Furthermore,ll rights reserved.
(F.S. Roman).there is evidence for a loss of 5-HT4 receptors in the cortex (23%),
and particularly the hippocampus (66%), of AD patients (Rey-
nolds et al., 1995).
In studies on rats, an increasing body of evidence supports a sig-
niﬁcant role of the 5-HT4 receptor type in learning and memory.
Most of these studies have observed a beneﬁcial effect of the rela-
tively non-selective agonists BIMU-1 and BIMU-8 on associative
learning in an olfactory discrimination task (Marchetti-Gauthier,
Roman, Dumuis, Bockaert, & Soumireu-Mourat, 1997), on social
memory (Letty et al., 1997), on acquisition of an operant autoshap-
ing task (Meneses & Hong, 1997), and on passive avoidance in mice
subjected to scopolamine-induced amnesia (Galeotti, Gheraldini, &
Bartolini, 1998). More selective compounds such as RS 17017 and
RS 67333 have also been shown to enhance cognition after hypox-
ia-induced amnesia in mice (Gherlardini et al., 1994) and on a de-
lay matching-to-sample task in aged primates (Terry et al., 1998).
Similar observations were made in rats tested for olfactory associa-
tive discrimination task (Marchetti et al., 2004; Marchetti, Dumuis,
Bockaert, Soumireu-Mourat, & Roman, 2000) and more recently in
the delayed spontaneous alternation task (Mohler et al., 2007).
These 5-HT4 agonists were also shown to attenuate atropine-in-
duced memory deﬁcits in a water-maze task (Fontana, Daniels,
Wong, Clark, & Eglen, 1997).
As therapeutic agents, however, these compounds generate sev-
eral undesirable side effects such as increased gastric motility, car-
diac ionotropy and tachycardia, as well as stimulation of the
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a selective 5-HT4 partial agonist such as SL65.0155 [5-(8-amino-7-
chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-[1-(2-phenylethyl)-4-
piperidinyl]-1,3,4-oxydiazol-2(3 H)-one monohydrochloride], such
side effects are not encountered––the drug acting as an antagonist
in peripheral tissues––whereas its cognitive-enhancing properties
can still be evidenced on several tests taxing learning and memory
(Moser et al., 2002).
In humans, pathologies associated with temporal lobe dysfunc-
tion, and particularly in mild AD, are characterized by selective
impairment of explicit or declarative memory. In rats with limbic
lesions, it is possible to use an olfactory associative discrimination
task, for instance, to show learning related to long-term reference
memory alterations vs. much weaker deﬁcits on procedural mem-
ory. Such a pattern of deﬁcits is similar in some aspects to the
dichotomy between relatively well-preserved non-declarative
and altered declarative memory found in humans after temporal
lobe damage.
In the present study, rats subjected to colchicine-induced le-
sions of dentate gyrus cells in the dorsal hippocampus, to create
lasting declarative-like memory deﬁcits (Jeltsch, Bertrand, Laza-
rus, & Cassel, 2001), were tested for the effects of a partial
selective 5-HT4 agonist (SL65.0155) on associative learning re-
lated to reference memory in an olfactory associative discrimi-
nation task.
2. Materials and methods
2.1. Animals
Twenty-eight young adult male Long-Evans rats (R. Janvier, France) weigh-
ing 250–275 g at the time of surgery were used. They were individually housed
and kept on a 24-h light-dark cycle (lights on at 7:00 am and off at 7:00 pm)
in a room held at a constant temperature (22 C). After surgery and before test-
ing, each animal was ﬁrst handled (10 min) every day for three days. Then it
was deprived of water 48 h before the beginning of training. During training
on the following days, the rats were given water ad libitum for 30 min per
day at 6:30 pm. For the reversal test, one month after the 6th training session,
the rats were deprived 24 h before the reversal session. European guidelines on
procedures for animal experimentation were followed (ofﬁcial authorizations to
H.J. # 67-14 and to J.-C.C. 67-215), and all efforts were made to minimize ani-
mal suffering and to reduce the number of animals used while complying with
statistical constraints.
2.2. Colchicine lesions
At approximately 90 days of age, the rats were assigned to two groups.
One group received bilateral intragyral infusions of colchicine (Sigma, St. Louis
MO) while the control group received an equal volume of vehicle alone (SHAM
group). All surgical procedures were conducted under aseptic conditions using
equithesin anesthesia (3.2 ml/kg; i.p.). Rats were lesioned using 3.0 lg of col-
chicine as described previously (e.g., Jeltsch et al., 2001). Colchicine, in a ster-
ile 0.1 M phosphate buffer (pH 7.4), was injected into ﬁve sites (0.1 ll was
delivered at each site over 1 min) along the dorsal extent of the dentate gyrus
in each hemisphere. Anteroposterior (AP), lateral (L), and vertical (V) coordi-
nates (in millimeters) were taken relative to Bregma (Paxinos & Watson,
1998): (1) AP = 2.2, L = ± 1.0, V = 5.0; (2) AP = 3.0, L = ±1.4, V = +4.9; (3)
AP = 4.0, L = ± 2.0, V = 4.8; (4) AP = 4.7, L = ±2.6, V = 5.1, (5) AP = 5.3,
L = ±3.5, V = 5.2. The incisor bar was placed at the level of the interaural line.
Injections were made through a 2.0 ll Hamilton syringe. After each injection,
the needle was left in situ for 2 min to allow diffusion before being slowly
retracted.
2.3. Drugs
The selective 5-HT4 partial agonist SL65.0155 was obtained from Sanoﬁ-Aven-
tis. It was dissolved in sterile saline solution (0.9% NaCl). SL65.0155 was injected
i.p. in the concerned rat group 30 min prior to the third training session. Injections
were administered before the beginning of the third training session because pre-
vious studies have revealed that during the third session, rats start to make correct
olfactory cue reward associations that required hippocampal activation (Chaillan
et al., 1997; Roman, Simonetto, & Soumireu-Mourat, 1993). The 0.01 mg/kg dose
was chosen on the basis of the data reported by Moser et al. (2002), who showed
that this dose leads to maximal enhancement of learning performance in rats.2.4. Apparatus and training procedure
The olfactory training apparatus was a rectangular box made of wire mesh
(30  30  50 cm). A conical odor port (1.5 cm in diameter, 0.5 cm above the ﬂoor)
was drilled horizontally through a triangular wedge of Plexiglas, mounted in one
corner of the cage. A circular (1 cm diameter) water port in the shape of a well
was placed directly above the odor port. Responses to the odor presentation were
monitored by a photoelectric circuit. Two ﬂashlight bulbs which could be turned
on and off, as the testing conditions required, were placed outside the cage, one
on each side of the odor and water ports, 10 cm above the ﬂoor. Individual odors
were delivered by forcing clean air (0.7 bars) through one of two 1000 ml Erlen-
meyer ﬂasks that contained 500 ml of water mixed (2‰) with chemical odorants.
The odor pair used was jasmine–strawberry. Non-odorized air was delivered by
sending air through a ﬂask that contained only water. Odorized and clean air
streams were passed individually through tubes that were put through the back
of the sound-attenuating chamber and attached to the odor port. Water was deliv-
ered using a gravity-fed system, and passed through a valve which, when opened,
allowed 0.1 ml of water to be released into the water port. The experiment was con-
ducted simultaneously in four cages to ensure training under the same conditions.
Animals were trained to make two odor-reward associations. Each odor had to be
associated with a speciﬁc reward, one arbitrarily designated as positive and the
other as negative, using a successive Go or No-Go paradigm. The rats had to ap-
proach the odor and water ports to interrupt the light beam during the 10-s presen-
tation of the positive odor. Response to the water port to the odor designated as
negative resulted in a 10-s presentation of non-aversive light. Water was only dis-
tributed with a response to the positive odor.
Individual trials were run in a quasi-random fashion, and either odor was pre-
sented for at most 10 s if the rat did not interrupt the light beam before that time.
Each new trial was started only when the subject left the corner where the reward
was distributed; if not, the trial was delayed for 10 s (cumulative time). In all cases,
a new trial could not start any earlier than 15 s after the termination of either water
or light delivery, or no response. A daily session was made up of 60 trials with an
inter-trial interval (ITI) of 15 s. Animals were tested every day between 08:00 am
and 02:00 pm.
Before the ﬁrst training session, all animals were placed for 15 min per day in
four similar olfactory training apparatuses for two days, and could drink 2 ml of
water distributed in the water port. Then, all animals were trained to make associ-
ations with the odor pair for six sessions at a pace of one session per day, before
being re-tested in one reversal session.
On this session, the valence of the previously learned odors was reversed: the
odor that had served as a positive stimulus in the training sessions was now a neg-
ative stimulus and vice versa. As in the previous training sessions, the reversal test
consisted of 60 trials. This last session was used to test the strength of the previ-
ously learned associations and to verify that the eventual effect observed during
learning sessions was not transient.
2.5. Experimental groups
At the end of the second session, the lesioned group was divided into two sub-
groups. One was the lesion control group in which rats were to be treated with the
vehicle (COL), while the other contained the rats to be treated with the 5-HT4 recep-
tor agonist (COL + SL65.0155). All rats from the SHAM group were injected with the
vehicle only.
2.6. Histological veriﬁcations
After completion of all behavioral testing, each rat was given an overdose of so-
dium pentobarbital (100 mg/kg; i.p.) and perfused transcardially with 100 ml of
0.9% saline, followed by 300 ml of 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.4, 4 C). After extraction, the brain was post-ﬁxed for about 4 h and transfered
into a 0.1 M phosphate-buffered 30% sucrose solution for about 36–40 h. Coronal
sections (30 lm) were cut on a freezing microtome and were collected onto gela-
tine-coated slides. The sections were dried at room temperature and stained with
cresyl violet (Sirkin, 1983). An evaluation of the extent of the lesions was performed
using the same morphometrical approach as in a former study (Jeltsch et al., 2001).
The areas of the remaining parts of the dentate gyrus and the Amnon’s horn were
measured in both hemispheres at 1.8, 2.8, 3.8 and 4.8 mm from Bregma (Pax-
inos & Watson, 1998). The comparisons considered the surface of each remaining
area at each level of anteriority with the data from the right and the left hemi-
spheres being added according to the hippocampal region considered. Based on
our previous ﬁndings showing no signiﬁcant difference between lesioned and
sham-operated rats, no measures were taken at 5.8 mm from Bregma (Jeltsch
et al., 2001).
2.7. Statistical analysis
Correct responses were Go for the positive odor and No-Go for the negative
odor. Incorrect responses were Go for the negative odor and No-Go for the positive
odor. The number of correct responses for both positive and negative odors was ex-
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ing a global estimate of performance for all groups. Training continued until a cri-
terion of 80 ± 5% correct responses was reached by the control groups. This level of
performance is required to ensure that all animals have made both associations
(Roman et al., 1993). Latencies for positive (S+) and negative (S) odors were re-
corded and represented the time elapsed between the beginning of a trial and its
end, when the rat responded to the odor. When a rat failed to respond, a latency
of 10 s was scored. In addition, because the subject could delay the trials by
responding during the inter-trial interval (ITI), the cumulative time was considered.
The median cumulative time was the number of seconds above the ﬁxed 15 s ITI,
divided by the number of ITIs, which in this experiment amounted to 59. All proce-
dural and behavioral events were controlled and recorded by a computer.
Statistical analyses were performed with SPSS/PC+ statistics 11.0 software mar-
keted by SPSS, Inc. and PRISM 2 (San Diego, USA). All data are presented as mean-
s ± SEM. Behavioral performance and histological results were analyzed using a
repeated-measure MANOVA. Then subsequent ANOVAs and post-hoc Newman–
Keul’s comparisons for each session were computed. For the reversal session, the
percentage of correct responses in comparison to chance levels was processed using
a one-sample t-test. The threshold for signiﬁcance was set at p 6 0.05 (on graphs:
*p 6 0.05; **p 6 0.01; ***p 6 0.001).
3. Results
3.1. Histological analysis
Typical examples of granule cell lesions in the dentate gyrus
and of pyramidal cell damage in the Ammon’s horn are illustrated
in Fig. 1. Examination of the sections stained with cresyl violetFig. 1. Illustrations of a typical colchicine-induced lesion on coronal sections thr-
ough the dorsal hippocampus stained with cresyl violet. (A) Injection of vehicle. (B)
Injection of 3.0 lg colchicine. Scale bar = 500 lm.showed extensive loss of granule cells in the dentate gyrus of all
rats subjected to colchicine injections, except for three rats, one
in the COL + SL65.0155 group, and two in the COL group. These rats
were discarded from the study. Consequently, the COL + SL65.0155
group was constituted of nine, and the COL group of eight rats.
In agreement with a previous report (Jeltsch et al., 2001), the
granule cell damage started already at about 1.8 mm from Breg-
ma and extended up to 4.8 mm. The lateral parts of the granule
cell layer were completely damaged bilaterally. There was a clear
cut disruption (no cell visible but layer thinner than in sham-oper-
ated rats) of one half to two thirds of the pyramidal cell layer in re-
gion CA1.
These observations were conﬁrmed by statistical analysis of the
morphometrical data (Table 1). When the total areas of the dentate
gyrus or the Ammon’s horn were analyzed (addition through all
four levels from Bregma), we found a signiﬁcant ‘‘Lesion” effect
in both regions [dentate gyrus: F (1,23) = 857.2, p < .0001; Am-
mon’s horn: F (1,23) = 177.6, p < .0001], which was due to the sig-
niﬁcant reduction of the global area in lesioned rats (65% in the
dentate gyrus and 32% in the Ammon’s horn, p < .001) as com-
pared to their sham-operated counterparts. The percentages were
computed as [(total area in lesioned/total area in intact) 
100]  100.
When the areas of the dentate gyrus and the Ammon’s horn
were compared at each level of anteriority, we found an overall
‘‘Lesion” effect in each of these two subregions of the hippocampus
[from 1.8 to 4.8 mm posterior to Bregma, F (1,23) > 26.0,
p < 0.001, at all levels and in each hippocampal subregion]. There
was no signiﬁcant difference between lesioned rats given saline
and those treated with SL65.0155, whatever the structure or the
level.
3.2. Behavioral studies
The performance of SHAM and COL + SL65.0155 rats improved
across sessions, reaching a correct response score of 80 ± 5% on ses-
sion 6. This improvement did not occur in the COL group (Fig. 2A).
MANOVAs indicated a group difference across the six sessions
[F (2,22) = 7.66, p < 0.01]. Separate ANOVAs showed a signiﬁcant
group difference starting on the fourth session [F (2,22) 6 4.52,
p < 0.05], and Newman–Keul’s tests revealed a signiﬁcant differ-
ence between the COL and SHAM rats from the 4th session on-
wards. On sessions 5 and 6, the difference between the COL and
COL + SL65.0155 rats was also signiﬁcant. Finally, whatever the
training session, there was no signiﬁcant difference between
COL + SL65.0155 and SHAM rats [ANOVAs: F (1,15) 6 3.13, NS].Table 1
Mean areas ± SEM of the dentate gyrus and the Ammon’s horn on coronal sections at
four levels (in millimeters) from Bregma in rats subjected to the intragyral injection of
vehicle (SHAM) or 3 lg colchicine (COL)
Anteriority from Bregma (in mm)
1.8 2.8 3.8 4.8
Dentate gyrus
SHAM 1.81 ± 0.05 4.22 ± 0.03 3.91 ± 0.2 4.31 ± 0.09
COL 0.82 ± 0.02* 1.13 ± 0.02* 1.22 ± 0.02* 1.65 ± 0.10*
Ammon’s horn
SHAM 6.55 ± 0.12 9.38 ± 0.30 11.91 ± 0.30 16.60 ± 0.22
COL 3.57 ± 0.13* 5.10 ± 0.30* 8.30 ± 0.40* 12.95 ± 010*
In COL rats, all values correspond to the surface of the remaining area of each
hippocampal subregion (left and right added at each anteriority level).
*Statistics: signiﬁcantly lower than in SHAM, p < 0.001. As there was no signiﬁ-
cant difference between lesioned rats treated with saline and those given
SL65.0155, data from both subgroups were collapsed.
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Fig. 2. Mean performance (±SEM) obtained across the six 10-trial sessions of 60 trials in rats injected with vehicle + saline solution (SHAM) (N = 8), colchicine (3.0 lg) + saline
(COL) (N = 8), or colchicine + SL65.0155 (COL + SL65.0155) (N = 9). Treated and control animals were injected 30 min before the beginning of the third session, as indicated by
the arrow. (A) Mean percentage of correct responses. The difference between the COL and SHAM groups was signiﬁcant, not that between the SHAM and COL + SL65.0155
groups. (B) Mean cumulative time (in seconds). (C and D) Mean latencies (in seconds), S+ are the latencies for the positive odor and S are the latencies for the negative odor.
The SHAM group started to make signiﬁcant associative discrimination on session 4 and the COL + SL65.0155 group, on session 5. Statistically signiﬁcant effects were tested
between S+ and S stimuli in SHAM (*) and in COL + SL65.0155 group (+).
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decrease from session one to session six in all three groups, and
there was no signiﬁcant difference across groups on any session
[MANOVA: group  session interaction F(2,22) = 2.06, NS].
On the S+ and S latencies pooled within each session, there
was a signiﬁcant difference across sessions between COL and
SHAM rats [MANOVA: F(1,30) = 15.26, p < 0.001] (Fig. 2C), but
not between the COL + SL65.0155 and SHAM rats [F(1,32) = 0.66,
NS] (Fig. 2D).
As illustrated in Fig. 2C, a latency difference between COL and
SHAM rats was observed for S+ stimuli [MANOVA: F(1,14) = 4.7,
p<0.05] and S stimuli [F(1,14) = 16.4, p < 0.001]. However, sepa-
rate ANOVAs for each session revealed that on S+ cues the differ-
ence was signiﬁcant only on session 3 [F(1,14) = 9.37, p < 0.01],
whereas on S cues, the difference started from session 3 and
was still found on sessions 4, 5, and 6 [F(1,14)P 9.31, p < 0.01].
This difference revealed that, except on the injection day (session
3) for the COL group, both groups decreased the time taken to re-
spond to the S+ stimuli, while only SHAM rats obtained gradually
increasing response times to the S stimuli from session 4 on-
wards. Consequently, SHAM rats demonstrated signiﬁcant learning
of the cue association, starting on session 4 [ANOVAs:
F(1,14)P 6.1, p < 0.05] (Fig. 2C and D), whereas COL rats never
reached a performance level reﬂecting correct associations be-
tween the cues and their respective rewards. On the other hand,
rats treated with SL65.0155 were able to perform correct discrim-
ination from session 5 onwards [ANOVA: F(1,16)P 4.6, p < 0.05](Fig. 2D). Consequently, following the agonist injection, there was
no longer a signiﬁcant difference between COL + SL65.0155 and
SHAM rats on S+ and S stimuli [MANOVAs: F(1,15) = 0.17, NS,
and F(1,15) = 0.77, NS, respectively].
The reversal session performed 30 days later had a percentage
of correct responses that was signiﬁcantly below the chance level
(Fig. 3A) in SHAM and COL + SL65.0155 rats [Student’s t-tests:
p 6 0.05], but did not differ from chance in COL rats. Performance
on cumulative time (Fig. 3B) was not signiﬁcantly different across
the three groups [MANOVA: F(2,22) = 3.2, NS], except on block 6
where the difference was signiﬁcant between COL + SL65.0155
and SHAM rats (Newman–Keul’s test: p < 0.05). As above, the
COL group responded similarly to S+ and S stimuli and no latency
difference was observed across the 6 blocks of trials [MANOVA:
F(1,14) = 0.15, NS], which reﬂects a generalization phenomenon,
the responses to the S+ and S stimuli being similar (Fig. 3C). Con-
versely, SHAM rats remembered the meaning of the previous odor
during the ﬁrst block [ANOVA: F(1,14) = 7.68, p < 0.01]. A signiﬁ-
cant difference between the COL and the COL + SL65.0155 groups
was observed across blocks on S+ cues [F(1,14) = 5.33, p < 0.05],
but not on S cues [F(1,14) = 3.33, NS]. This difference was not ob-
served between SHAM and SL65.0155 rats (Fig. 3D), on S+ or S
latencies, whether pooled [MANOVA: F(1,32) = 3.7, NS], or taken
separately [F(1,32) 6 1.98, NS; S: F(1,32) = 2.2, NS]. As in the
SHAM rats, agonist-treated rats were able to remember the previ-
ous meaning, with a latency difference between S+ and S stimuli
that was signiﬁcant on the ﬁrst block [ANOVA: F(1,16) = 7.44,
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Fig. 3. Mean performance (±SEM) on session 6 (S6), and one month later during a reversal session (Reversal). On the reversal session, the valence of the previously learned
odors was reversed. (A) Overall percentage of correct responses obtained across the 60-trial sessions. *Statistically signiﬁcant effects were tested in comparison to chance
(50%) (B, C and D) Mean performance by 10-trial blocks found during the last 10 blocks on session 6, then across the 6 blocks during the reversal session. SHAM (C or D) and
COL + SL65.0155 (D) groups remembered the previously learned odor-reward associations on the ﬁrst block of 10 trials in the reversal session. Statistically signiﬁcant effects
were tested between S+ and S stimuli in SHAM (*) and in COL + SL65.0155 group (+).
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was the same, whatever the block.
4. Discussion
As previously reported, bilateral administration of 3.0 lg of col-
chicine into the dentate gyrus caused signiﬁcant shrinkage of this
structure, an extensive loss of granule cells associated with dam-
age encroaching onto one-half to two-thirds of the pyramidal cell
layer in region CA1 (Jeltsch et al., 2001). When tested in T-maze,
radial-maze, and water-maze tasks, rats with such lesions exhib-
ited substantial deﬁcits in both reference- and working-memory
performance (Jeltsch et al., 2001). Using an olfactory associative
discrimination task, we extended these ﬁndings by showing here
that lesioned rats were unable to correctly learn odor-reward asso-
ciations. Overall performance levels, as assessed by the percentage
of correct responses, were never different from chance in rats with
lesions, whereas SHAM rats exhibited signiﬁcant learning from the
fourth session onwards. This deﬁcit was not due to an impairment
of the procedural aspect of the task, since the cumulative time did
not differ across groups. In fact, although the lesioned rats were
able to learn the temporal aspect of the task, which consisted in
moving away from the detection area during the inter-trial delay,
they responded indifferently to S+ and S cues. After six training
sessions, no associative discrimination (as measured by latencies)
was observed in lesioned rats. The reversal session performedone month later conﬁrmed this speciﬁc deﬁcit, with no latent
learning of the associations, while no procedure forgetting was ob-
served in comparison to SHAM rats.
The most interesting contribution of the present study is the
ﬁnding that lesioned rats treated with the 5-HT4 agonist
SL65.0155 recovered learning and memory performance, for they
reached a level of about 80% correct responses on session 6 (which
did not differ from that found for SHAM rats). As no effect was seen
on the procedural aspect of the task, as in lesioned rats given
saline, it can be concluded that SL65.0155 re-established close-
to-normal associative learning related to reference memory capa-
bilities. The beneﬁcial effects of the treatment were progressive,
as they started to emerge on the third session and resulted in
signiﬁcant improvement on session 5 and an even larger improve-
ment on session 6. Consequently, recovery was complete on ses-
sion 6 (in comparison with the SHAM rats). This result was
conﬁrmed one month later during the reversal session, where like
the SHAM rats, lesioned rats treated with SL65.0155 reached a per-
centage of correct responses that was signiﬁcantly below the
chance level. These results show that 5-HT4 receptor activation
may foster robust cognition-enhancing effects in a model of partial
temporal lobe damage (Marchetti et al., 2004, 2000, 1997).
Indeed, while conﬁrming the therapeutic potential of 5-HT4
agonists in cognitive pathologies (Moser et al., 2002), the 5-HT4
receptor agonist, SL65.0155, might be particularly well-suited to
treating pathologies associated with temporal lobe dysfunction.
190 E. Marchetti et al. / Neurobiology of Learning and Memory 90 (2008) 185–191This beneﬁcial behavioral effect can be explained in several ways.
First, 5-HT4 receptors are largely present throughout the limbic
structures and not just in the hippocampus, and it is quite possible
that their activation in undamaged regions of the limbic system
may have compensated for the dysfunctions related to the dis-
rupted granule cells, and to a lesser extent the pyramidal cells. Sec-
ond, although the immunolocalization of 5-HT4 receptors has not
yet been precisely determined, pre- or post-synaptic activation
by 5-HT4 receptor agonists has been shown to increase releases
from cholinergic, GABAergic (dentate gyrus), dopaminergic, and
serotoninergic neurons (see Bockaert, Claeysen, Bécamel, Dumuis,
& Marin, 2006 for a review), and all these neuropharmacological
consequences may contribute to enhancing cognition. In addition,
recent data demonstrated that activation of 5-HT4 receptors im-
proved spontaneous alternation performance and increased hippo-
campal ACh output only under the delayed spontaneous condition,
but did not signiﬁcantly modify ACh output in the resting condi-
tion (Mohler et al., 2007). Indeed, this selective modulation of hip-
pocampal ACh output may allow an increase in cholinergic tone
that corresponds to speciﬁc cognitive demands (improving sig-
nal-to-noise), rather than a global increase in ACh induced with
AChE-Is (generally increasing ‘‘gain” in the system) (Sarter, Has-
selmo, Bruno, & Givens, 2005). This possibility is further supported
by data showing that 5-HT4 receptors take part in the activation
and remodeling of experience-induced synaptic contacts, because
5-HT4 receptor agonists can modulate long-term potentiation
(LTP) and long-term depression (LTD) in the hippocampus or
amygdala (Huang & Kandel, 2007; Kemp & Manahan-Vaughan,
2004; Kulla & Manahan-Vaughan, 2002; Marchetti et al., 2004).
The activation of 5-HT4 receptors also results in increased cAMP
concentrations and leads to the inhibition of voltage-gated K+
channels (Ansanay, Dumuis, Sebben, Bockaert, & Fagni, 1995; Fag-
ni, Dumuis, Sebben, & Bockaert, 1992), thereby enhancing neuronal
activation. It has also been found that 5-HT4 receptor activation re-
duces after hyperpolarization and attenuates the spike accommo-
dation phenomenon in CA1 pyramidal neurons (Andrade &
Chaput, 1991; Torres, Arfken, & Andrade, 1996). All these effects
are mediated by cAMP and protein kinase A activation. Knowing
that a direct relationship exists between PKA-related calcium per-
meability of NMDA receptors and experience-dependent synaptic
remodeling, the activation of 5-HT4 receptors is likely to play a
modulatory role in hippocampal memory-related processes (Ske-
berdis et al., 2006). Indeed, the preferential location of 5-HT4
receptors on the somata of hippocampal glutamatergic CA1 cells
(Bickmeyer, Heine, Manzke, & Richter, 2002) is likely to play a cru-
cial role in this process. Based on our present results, this seems to
remain true following granule and, to a lesser extent, pyramidal
cell damage in the dorsal hippocampus. In addition, more recently,
it has been demonstrated that treatment with the 5-HT4 agonist RS
67333 over 3 days was followed by an activation of adult hippo-
campal neurogenesis (Lucas et al., 2007). Such effect with other
antidepressants occurring only after 2–3 weeks (Castren, 2004;
Malberg, Eisch, Nestler, & Duman, 2000). Moreover, SL65.0155 in-
jected prior to four training sessions enhanced simultaneous olfac-
tory discrimination performance and potentiated learning-induced
dendritic spine growth in the mouse hippocampus (Restivo et al.,
2007), providing evidence that 5-HT4 stimulation selectively in-
creases experience-dependent structural plasticity in learning-
activated hippocampal circuits. In our study, histological quantiﬁ-
cation performed one month after 5-HT4 agonist SL65.0155 injec-
tion, show no signiﬁcant difference between lesioned rats given
saline and those treated with SL65.0155.
The data reported here, in addition to previous electrophysio-
logical approaches (Spencer et al.,2004) and to investigations in
animal models of amnesia (Micale, Leggio, Mazzola, & Drago,
2006), indicate that the activation of 5-HT4 receptors bySL65.0155 could be a promising way to treat some impaired mem-
ory symptoms related to dysfunctions in the hippocampal forma-
tion, as found in Alzheimer’s disease. Testing the effects of this
compound in models based on cholinergic lesions in the basal fore-
brain or/and lesions of the entorhinal cortex (Traissard et al., 2007),
two neurodegenerative signatures of Alzheimer’s disease, might be
worth further investigation.
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